DOCSLIB.ORG

PRESIDE Magazine Volume 1, Nov. 2020 Page 22

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Volume 1, Nov. 2020 MAGAZINE PRESIDE COVID-19 in Uganda Is the Science Working? Volume 1, Nov. 2020 1 © PRESIDE Magazine A4 Magazine Ad.pdf 1 10/11/2020 17:04 CONTENTS We cannot Afford to Lag Behind in Science and Technology 6 Again C COVID-19 IN UGANDA: Is the Science Working? M WRITERS: 8 Y • Dr. Monica M. Musenero Combatting COVID-19: Uganda’s race against the CM • Prof. Vinand Nantulya 13 Clock MY • Dr. Sheila Balinda CY • Prof. William Bazeyo Safely Operating Schools amidst COVID-19 CMY • Dr. Serukka David 16 K • Brenda Ayugi Ojara • Eric Mwima Uganda has potential to develop COVID-19 Vaccine • Dr. Jeremiah Twa-Twa. 19 • Dr. Maxwell Otim Onapa • Brenda Nakazibwe 22 Epi Tent -The Tent That Breathes • Abel Wilson Walekhwa • Mary Nantongo Lukenge 25 The Science of the Mask EDITOR: • Paul Watuwa Timbiti Does Uganda’s health system have the capacity to 28 treat COVID-19 Patients? CHIEF EDITOR: • Dr. Charles Wendo 30 A balanced diet means more life against COVID-19 COMPILED BY: Ministry of Science and Technology and PRESIDE partner • Cathy Muwumuza 23 to support COVID-19 Research and Innovation CREATIVE DESIGNER: What do COVID-19 Statistics mean? • Gilgal Media Arts 35 PUBLISHED BY: 37 Ask Doctor PRESIDE! The Presidential Scientific Initiative on Epidemics Want to take a COVID-19 Test - Where do I go? (PRESIDE) 39 2 PRESIDE Magazine Volume 1, Nov. 2020 3 Dear Countrymen and women, have the honour to welcome you to the first issue of this quarterly PRESIDE magazine. It is a publication whose pages we have pervaded with exciting views and other Ieducative materials on the theme that was appropriately chosen given the current pandemic of COVID-19, but also cognizant of the International Science Day approaching on 10th November 2020, that will also be celebrated here in Uganda and you cannot wait to learn more about it. I know you are anxious to learn about the theme for this Editor in Chief issue; interestingly, it is COVID-19 in Uganda. Is science working? You should explore this in our exciting articles Dr. Charles Wendo well thought out by our own experts. [email protected] We bring you Dr. Monica Musenero Masanza, the senior presidential advisor on epidemics (SPADE), who answers some of your questions every Saturday in The Saturday CPHL Ad Vision. In this issue, however, you have the chance to learn more about her works, including her vision for science in Uganda. The magazine has also been mellifluously packaged to bring you an extensive coverage of how Uganda successfully ran the COVID-19 race, subsequently getting recognized by Lancet among the best performing countries in the COVID-19 fight. Lastly, body immunity being crucial in resisting COVID-19, we bring you exciting and exhaustive information on how to boost your immunity through nutrition, but also where to go in case you would like to do a COVID-19 test in Uganda. You can only miss this if you must. Would you like to know more about PRESIDE? Read more and watch out for more releases moving forward. I remain your editor in chief. 4 PRESIDE Magazine Volume 1, Nov. 2020 5 MESSAGE From H.E. Yoweri K. Museveni We cannot Afford to Lag Behind in Science and Technology Again and technology again. We must cure the original sin of backwardness which contributed to our being dominated by other superior races and ravaged by nature. he major factor for the evolution of our With these unique capabilities, man was able to I am glad to note the great scientific awakening in Uganda in the various fields. This is a significant species, homo sapien, as the most dominant invent fire, agriculture, iron tools etc. Each of these achievement because we are beginning to see our scientists emerge with locally developed solutions to creatures on earth is that we developed the inventions significantly improved man’s quality of the challenges we face. Tcapacity to tame nature. This meant that finally, life and also enabled us to live longer. we were able to free ourselves from the oppression While other parts of the world continued to subdue This is the path that we must take and the NRM Government will continue to support our scientists of man by nature in the form of floods, drought, nature to serve their interests, the Africans remained to further research and product development. As the human race enters the 4th Industrial Revolution diseases, landslides, famine etc. Man’s uniqueness stagnant at the initial inventions of early man. We of Artificial revolution, let us not again make the terrible mistake of remaining mere spectators like lies in his ability to establish dominion over nature missed out on the first industrial revolution which our ancestors. through conscious actions. ushered the change from a reliance on muscle power to machine power. We were again spectators in the There are three special features which enabled us to second industrial revolution, which was the invention have meaningful impact on the environment. These of electricity. We also missed out on the third include: possession of a large brain, a hand that could industrial revolution which involved automation of hold and shape tools and bipedalism or walking on machines. Our failure to participate in these three Yoweri Kaguta Museveni two legs, which fact freed man’s head to think better industrial revolutions was a big disadvantage on our President of the Republic of Uganda and his eyes to see far. On account of these, man was part. It meant that we remained backward in terms of able to think of solutions to the problems he faced science and technology. and to make tools that could assist him to satisfy his needs. Therefore, we cannot afford to lag behind in science 6 PRESIDE Magazine Volume 1, Nov. 2020 7 will then attempt to show evidence of whether it is Strategic Level – Presidential, working or not. Prime Minister and Minister’s Over the past two decades Uganda has trained both Advisory Scientific Team locally and in foreign institutions and this has built The national response is coordinated by His a considerable human resource pool covering a wide Excellency, the President of Uganda, who chairs COVID-19: range of scientific expertise. Ugandan scientists have the National COVID-19 Task Force with overall participated in many research projects both here responsibility for the broad policy decision making. and internationally. Uganda is also well known for The agreed policies are presented to Cabinet for Is the Science her highly proficient epidemic response workforce debate and if passed, are adopted for implementation. which has prominently supported international The multi-sectoral operational coordination is done Working? epidemic response efforts whenever called upon. at Prime-ministers level. The president appointed a However, until this COVID-19 pandemic, many of Senior Presidential Advisor on Epidemics (SPADE) these experts, especially those embedded in academic who permanently works with him in collaboration institutions had not been called upon to actively with a team of experts to provide scientific advice Dr. Monica Musenero Masanza participate in the previous national epidemic control to that level of decision making. The SPADE also Senior Presidential Advisor Epidemics & Chair, efforts. supports Prime Ministerial level and other sectors in PRESIDE their decision making in the context of COVID -19. Why Science and Scientists? At sector level, the Minister of Health appointed the ganda’s ongoing battle with COVID-19, knowledge in the form of testable explanations and As COVID-19 spread from China and threatened Scientific Advisory Committee, consisting of a team has put an unusual limelight on her hitherto predictions about physical life. Therefore a scientist to reach every country in the world, it became of experts drawn from various institutions, chaired hidden scientists. Science and scientists have is an individual well versed with at least one branch apparent that each country would have to strongly by Professor Misaki Wayengera, from Makerere Ubeen repeatedly referred to by His Excellency the of science. rely on her indigenous scientific human capital to University, to advise into the multiple aspects of President during his national addresses. The Minister control the disease. Unlike the other recent severe the technical response. They undertake extensive of Health has often appeared with scientists besides Uganda’s COVID-19 response has been anchored but geographically restricted epidemics such as the synthesis of all information emerging from ongoing her while updating the public about COVID-19. in Science where all key decisions have been made Ebola in West Africa and DRC, where international research globally and thus ensuring that each and Scientists themselves have been quoted or appeared through critical scientific analyses by experts in agencies such as the World Health Organization every intervention is backed by scientific credibility in various media guiding the public about various multiple areas. Various aspects of science have would globally source experts to support affected to the best of available knowledge. Responsibilities issues related to the pandemic. In addition, during been applied to the designing of field interventions countries, for COVID-19 each and every country have included, recommending diagnostic tests, this period, His Excellency has repeatedly appealed (Epidemiology), diagnosis (Laboratory science), would need their experts. strategies for field containment, treatment protocols, for improvement of emoluments to scientists at the case management
Recommended publications
  • Fighting Ebola: Voices from the Frontline Documenting the Experiences of East African Deployed Experts Who Volunteered to Fight Ebola in West Africa Implemented By

    Fighting Ebola: Voices from the Frontline Documenting the Experiences of East African Deployed Experts Who Volunteered to Fight Ebola in West Africa Implemented By

    Fighting Ebola: Voices from the Frontline Documenting the experiences of East African deployed experts who volunteered to fight Ebola in West Africa Implemented by: Fighting Ebola: Voices from the Frontline Documenting the experiences of East African deployed experts who volunteered to fight Ebola in West Africa Contents Introduction . 6 Foreword from the Hon . Jesca Eriyo . 9 Foreword from Dr Zabulon Yoti . .. 10 Foreword from Dr Jackson Amone . 12 Foreword from Dr Irene Lukassowitz . 13 George Acire . 14 Rebecca Racheal Apolot . 17 Sarah Awilo . 22 Dr Mwaniki Collins . 24 Charles Draleku . 26 Emmanuel Ejoku .. 28 Dr Madina Hussein . 31 Loveness Daniel Isojick . 34 Dr Abdulrahman Said Kassim . 36 Teddy Kusemererwa . .. 40 Liliane Luwaga . 43 Dr Appolinaire Manirafasha . 46 Dr Landry Mayigane . 48 James Mugume . 50 Dr Monica Musenero . 52 Doreen Nabawanuka . 55 Dr Bella Nihorimbere . 56 Teresia Wairimu Thuku . 57 Tony Walter Onena . 59 Acknowledgements . 61 4 Fighting Ebola: Voices from the Frontline 5 Introduction ccording to the World Health Organization (WHO), Others, seeing scenes of death and devastation on their The East African Community Secretariat, in collaboration the Ebola epidemic that occurred in West Africa television screens, just felt compelled to do whatever they with the Federal Government of Germany through the Abetween 2014 and 2016 killed over 11,000 people could to help . Given that so many West African health GIZ-coordinated Support to Pandemic Preparedness in out of the almost 30,000 that were infected . From one
  • One Health Workforce Project

    One Health Workforce Project

    One Health Workforce Project John Deen One Health Workforce Project Part of USAID’s EPT2 Program Emerging Threats Program Emerging Threats Program Each civil society needs the capacity and confidence to defend itself Emerging Threats Program Invasion by pathogens • Significant death and morbidity • Large amount of disruption – Health system – Economy – Agriculture – Trade – Politics • Large influx of aid is also disruptive • A breakdown in civil society Emerging Threats Program Factors for Human Disease Emergence . 1415 species of infectious agents reported to cause disease in humans . Viruses, prions, bacteria, rickettsia, fungi, protozoa, helminths . 868/1415 (61%) zoonotic . 175 emerging infectious diseases . 132/175 (75%) emerging zoonoses Taylor et al. Risk factors for disease emergence. 2001, Philosophical Transactions, The Royal Society, London Emerging Threats Program Human Cases One Health – Public health Wild Animal Domestic Animal as part of a larger “ecosystem” Animal Amplification C A Wildlife Surveillance/ S Forecasting Early Detection Control E Opportunity S Human Amplification TIME Which predicts a country’s susceptibility to a pathogen? Agent or Host? Emerging Threats Program Eg Ebola • The presence of the agent (R0 <2) • The presence of a host defense (Workforce plus government capacity) Emerging Threats Program National One Health Workforce • Competent • Inspired • Empowered To • Prevent • Detect • Respond Emerging Threats Program History • SARS IHR aim of 100% of countries compliant • Ebola, MERS IHR at 32%, PVS lower
  • Lessons for the Future

    Lessons for the Future

    Lessons for the Future What East African experts learned from fighting the Ebola epidemic in West Africa A regional conference with international participation held in Nairobi, Kenya from 6th to 8th November 2017 Lessons for the Future What East African experts learned from fighting the Ebola epidemic in West Africa A regional conference with international participation held in Nairobi, Kenya from 6th to 8th November 2017 Conference Report Implemented by: Contents List of Abbreviations . 5 Foreword . 7 Summary . 8 Introduction . 9 East joins West in the fight against Ebola . 10 A wealth of experience . 11 Objectives of the conference . 11 Conference methodology and brief programme overview . 12 Voices from the Ebola frontline: Documenting a treasure trove of experience . 12 Day one: Welcoming delegates to Kenya . 16 Opening speech by Dr Monica Musenero . 17 Germany’s experiences of establishing a database of rapidly deployable experts . 19 First sharing of experiences . 20 Exploring eight themes . 20 The first four pre-set themes . 21 The four themes subsequently chosen by the participants . 21 Theme 1: Being ready at short notice – establishing a pool of deployable experts . 22 What worked well? . 22 What did not work well? . 22 Lessons learned . 24 Recommendations . .. 24 Theme 2: Taking informed decisions – effective communication to mitigate risks and crises . 25 What worked well? . 25 What did not work well? . 25 Lessons learned . 27 Recommendations . .. 28 Theme 3: Working together - One Health . .28 What worked well? . 28 What did not work well? . 29 Lessons learned . 29 Recommendations . .. 30 Theme 4: Effective logistics – what, where, when and how? . 31 What worked well? .
  • Medical Research Category Jean-Jacques Muyembe-Tamfum (DRC)

    Medical Research Category Jean-Jacques Muyembe-Tamfum (DRC)

    Medical Research Category Jean-Jacques Muyembe-Tamfum (DRC) Born in the DRC in 1942. Obtained M.D. at University of Lovanium (present University of Kinshasa), and Ph.D. (Medicine/Virology) at Rega Institute for Medical Research, Catholic University of Leuven (Belgium). Current General Director, National Institute of Biomedical Research (INRB) and full Professor of Medical Microbiology/Virology, Faculty of Medicine, University of Kinshasa The Third Hideyo Noguchi Africa Prize for Medical Research goes to Dr. Jean- Jacques Muyembe-Tamfum for his research to confront Ebola and other deadly viruses and efforts to train legions of disease-fighters. Dr. Jean-Jacques Muyembe-Tamfum has for more than five decades displayed outstanding courage, intelligence and scientific rigor in research and training in the DRC. In particular, in 1976 he identified the existence of a previously unknown disease in his country, collected blood and tissue samples under dangerous conditions, and forwarded them to the Institute of Tropical Medicine in Belgium where the Ebola virus was discovered. Since 1976 Dr. Muyembe-Tamfum has been on the front lines of Ebola research, identifying nosocomial and burial transmission as two of the major causes of disease transmission, contributing to vaccine research, developing antisera therapy and training a new generation of disease responders and Congolese laboratory scientists. Summary of Achievements Dr. Jean-Jacques Muyembe-Tamfum is an African scientist who was dispatched to Yambuku, a small village in northern area of DRC, where the first outbreak of Ebola virus disease (EVD) occurred in 1976, and he raised an alert about the disease. Since then, he has worked as an expert in tackling and controlling EVD.
  • The Sdgs and the Game Change in Global Health

    The Sdgs and the Game Change in Global Health

    The SDGs and the Game Change in Global Health Organised by the Global Health Programme, the Graduate Institute, Geneva Biographies of Speakers 12 November 2015 Maison de la paix The Graduate Institute, Geneva WELCOME AND INTRODUCTORY REMARKS BY THE MODERATOR OF THE SESSION ILONA KICKBUSCH Director, Global Health Programme, the Graduate Institute Ilona Kickbusch is the Director of the Global Health Programme at the Graduate Institute of International and Development Studies, Geneva. She is senior advisor to the Regional Directors of the WHO Regional Offices for Europe and the Eastern Mediterranean. She has been deeply involved in the development of the Health 2020 European health policy framework. She is a member of the independent Ebola interim assessment panel of the WHO. In Switzerland she serves on the executive board of the Careum Foundation and on the expert panel to the Federal Councillor to advice on the implementation of the Swiss Health Strategy 2020. She has contributed to innovation in health in many ways throughout her career and now advises organisations, government agencies and the private sector on policies and strategies to promote health at the national, European and international level. She has worked with the WHO at various levels and in academia as professor at Yale University. She has received honorary doctorates from the Nordic School of Public Health and the University of Girona. She has published widely and is a member of a number of advisory boards in both the academic and the health policy arena. She has received many awards. Her key areas of work relate to Global Health Governance, Health Security, Public Health, Health Promotion, Health Literacy and Health in All Policies.
  • UNIPH Epidemiological Bulletin

    UNIPH Epidemiological Bulletin

    MINISTRY OF HEALTH UGANDA Epidemiological Bulletin UNIPH Volume 1| Issue 2 | Dec 2016 Quarterly Epidemiological Bulletin of the Uganda National Institute of Public Health, Ministry of Health October—December 2016 EDITORIAL TEAM Dr Monica Musenero | Dear Reader, ACHS , Epidemiology & Surveillance Division, MoH Welcome to the 5th edition, Issue 2 Volume 1 of the Uganda Dr Immaculate Nabukenya | National Institute Public Health (UNIPH) Quarterly Epidemio- logical Bulletin. ACHS, Veterinary Public Health, MoH This bulletin aims to inform the district, national, and global Dr Alex Riolexus Ario | stakeholders on the public health interventions, evaluation of Field Coordinator, Uganda Public Health Fellowship surveillance systems and outbreak investigations undertaken in Program, Uganda National Institute of Public Health, disease prevention and control by Ministry of Health. MoH In this issue, we present highlights on evaluation of surveillance system in emergence setting, chemical poisoning due to con- Ms Leocadia Kwagonza | sumption of a dead pig, chemical poisoning in a flower farm and PHFP-FET, Fellow, Uganda Cancer Institute (UCI) Typhoid misdiagnosis among others. These studies generated evidence and results which will be used to inform planning and Ms Joy Kusiima interventions in the country and beyond. PHFP-FET Fellow, Uganda Cancer Institute (UCI) For any further information regarding the articles, feel free to Ms Claire Birabawa contact us at: [email protected] OR lkwagon- [email protected] PHFP-FET Fellow, Division of Health Information, We will appreciate any feedback regarding the content and gen- MoH eral outlook of this issue and look forward to hearing from you. Dr Phoebe Hilda Alitubeera We hope this will be both an informative and enjoyable reading for you.
  • The Contribution of Professional Associations

    The Contribution of Professional Associations

    Professional Assocs The contribution of professional associations Francis Omaswa and Rosemary Mugwe trace the journey of the Association of Surgeons of East Africa (ASEA) to the College of Surgeons of East, Central and Southern Africa (COSECSA) The Association of Surgeons of East Africa (ASEA) was should be put in practice in a selected remote setting in launched in 1950 at a meeting in Nairobi, Kenya by East Africa. This later became the Ngora Hospital Project expatriate surgeons from Kenya, Tanganyika (now Tanza- on Cost Effective Rural Surgery of which Francis Omaswa nia) and Uganda. The story of ASEA and its founders is an became the Project Director and Medical Superintendent example of socially accountable professionals in the colo- of that hospital. nial health service who decided that they needed to meet ASEA also set up specialist training positions in Urol- regularly to discuss how they could serve the population ogy in Moshi, Tanzania and Orthopedic Surgery in Bula- better and also enjoy fellowship and the company of each wayo, Zimbabwe, and Lusaka, Zambia. other. At that time there were no indigenous Africans who In 1985 another Symposium was held in Nyeri, Kenya were specialised as surgeons. The frst President of ASEA on the theme Surgery in Africa in the year 2000. It was was C.V. Braimbridge from Nairobi, who was succeeded at this meeting that a paper on postgraduate training a few years later by A.J. Boase, also from Nairobi, and was discussed. Concerns regarding the quality of the M. John Croot and Ian McAdam, both from Kampala.
  • Sexual and Reproductive Health Rights for Youth and Adolescents

    Sexual and Reproductive Health Rights for Youth and Adolescents

    THE IssueHealth 08 June 2016 Digest Sexual and Reproductive Health Rights for Youth and Adolescents Youth-friendly corners boost uptake of sexual and reproductive health services End Forced Sterilization of Women Living with HIV Writing Women’s Reproductive Health: A Uganda Study Inside This Issue 1. Table of Contents ....................................................................................................................... Page 1 2. Message from the Editor .......................................................................................................... Page 2 3. Message from the Managing Editor ............................................................................................ Page 3 4. Youth-friendly corners boost uptake of sexual and reproductive health services .......... Page 4 5. End forced sterilization of women living with HIV ................................................................ Page 8 6. HIV positive teenagers grapple with stigma in boarding schools ..................................... Page 10 7. Is the vaginal ring the future .......................................................................................................... Page 12 8. Time to act is now ........................................................................................................................ Page 14 9. Young males in Kampala shun sexual and reproductive services ..................................... Page 16 10. Policy guideines on sexual and reproductive health are not helping ....................................
  • Quarantine Sierra Leone

    Quarantine Sierra Leone

    QUARANTINE IN SIERRA LEONE Lessons Learned On the use of quarantine in Sierra Leone as a support measure during the Ebola Epidemic 2014-2015 Laura Sustersic for Welthungerhilfe Sierra Leone Freetown April 2015 TABLE of CONTENTS 1. INTRODICTION 3 1.1 THE CONTEXT: EBOLA EPIDEMICS IN HISTORY 4 2. BRIEF OVERVIEW OF OUTBREAK AND WHH ENGAGEMENT 5 3. PRINCIPLES AND USE OF QUARANTINE FOR EBOLA CONTAINMENT 6 3.1 PUBLIC HEALTH PRINCIPLES AND INFECTIOUS DISEASES 6 3.2 PRINCIPLES OF EBOLA CONTAINMENT 6 3.3 MONITORING OF CONTACTS 7 3.4 CHOOSING QUARANTINE IN SIERRA LEONE 8 4. IMPLEMENTING GOOD QUARANTINES IN SIERRA LEONE 10 4.1 HHQ, FLOW CHART WITH STAKEHOLDERS 11 4.2 ELEMENTS TO IMPLEMENT SUCCESSFUL HOUSEHOLDS QUARANTINE 12 4.2.1 CONTACT TRACING 12 4.2.2 RESPECTING BASIC HUMAN RIGHTS 12 4.2.3 RECOGNIZING ROLES AND RESPONSIBILITIES OF INDIVIDUALS IN QUARANTINE 13 4.2.4 COMMUNITY SUPPORT 13 4.2.5 SECURITY 13 4.3 PROBLEMS ASSOCIATED WITH QUARANTINE 14 4.3.1 ISSUES WITH OTHER RESPONSE PILLARS 15 4.3.2 SHORTCOMINGS IN QUARANTINE SUPPORT SERVICES 15 4.3.4 ISSUES DIRECTLY RELATED TO QUARANTINE 16 4.3.5 ISSUES TO BE VERIFIED OR FURTHER DISCUSSED 16 4.4 SPECIAL CASE OF QUARANTINE IN SLUMS 16 5. LESSONS LEARNED 17 6. CONCLUSIONS 18 ANNEX 1-EBOLA OUTBREAK IN SIERRA LEONE 19 DERC District Ebola Response Centre EVD Ebola Virus Disease HH Households MoHS Min. of Health and Sanitation MSF Medicines Sans Frontières NERC National Ebola Response Centre NFI Non Food Items Q Quarantine SOP Standard Operating Procedures UNMEER UN Mission for Ebola Emergency Response VIP Ventilated Improved Pit-latrines WA Western Area District WASH Water, Sanitation and Hygiene WHH Welthungerhilfe WHO World Health Organization 2 1.
  • Complete Issue (PDF)

    Complete Issue (PDF)

    Dedicated to what works in global health programs GLOBAL HEALTH: SCIENCE AND PRACTICE 2020 Volume 8 Number 2 www.ghspjournal.org EDITORS Editor-in-Chief Stephen Hodgins, MD, MSc, DrPH, Associate Professor, Global Health, School of Public Health, University of Alberta Editor-in-Chief Emeritus: James D. Shelton, MD, MPH, Retired Associate Editors Matthew Barnhart, MD, MPH, Senior Science Advisor, USAID, Bureau for Global Health Cara J. Chrisman, PhD, Biomedical Research Advisor, USAID, Bureau for Global Health Elaine Menotti, MPH, Health Development Officer, USAID, Bureau for Global Health Jim Ricca, MD, MPH, Learning and Implementation Science Team Leader, Maternal and Child Survival Program, Jhpiego Madeleine Short Fabic, MHS, Public Health Advisor, USAID, Bureau for Global Health Saad Abdulmumin, MD, PhD, MPH, USAID, Bureau for Global Health Malaria: Michael Macdonald, ScD, Consultant, World Health Organization, Vector Control Unit, Global Malaria Programme Maternal Health: Marge Koblinsky, PhD, Independent Consultant Nutrition: Bruce Cogill, PhD, MS, Consultant Managing Staff Natalie Culbertson, Johns Hopkins Center for Communication Programs Sonia Abraham, MA, Johns Hopkins Center for Communication Programs EDITORIAL BOARD Zulfiqar Bhutta, The Hospital for Sick Children, Toronto, Aga Emmanuel (Dipo) Otolorin, Jhpiego, Nigeria Khan University, Pakistan James Phillips, Columbia University, USA Kathryn Church, Marie Stopes International, London School Yogesh Rajkotia, ThinkWell, USA of Hygiene and Tropical Medicine, United Kingdom David
  • Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008 Joseph F

    Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008 Joseph F

    Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008 Joseph F. Wamala, Luswa Lukwago, Mugagga Malimbo, Patrick Nguku, Zabulon Yoti, Monica Musenero, Jackson Amone, William Mbabazi, Miriam Nanyunja, Sam Zaramba, Alex Opio, Julius J. Lutwama, Ambrose O. Talisuna, and Sam I. Okware During August 2007–February 2008, the novel Bun- distinct species of Ebola virus were known: Zaire ebolavi- dibugyo ebolavirus species was identifi ed during an out- rus, Sudan ebolavirus, Côte d’Ivoire ebolavirus, and Res- break of Ebola viral hemorrhagic fever in Bundibugyo ton ebolavirus. district, western Uganda. To characterize the outbreak as Although the reservoirs for the virus and mechanisms a requisite for determining response, we instituted a case- of transmission have not been fully elucidated, a recent series investigation. We identifi ed 192 suspected cases, of study reported that 4% of bats from Gabon were positive which 42 (22%) were laboratory positive for the novel spe- cies; 74 (38%) were probable, and 77 (40%) were negative. for Zaire Ebola virus immunoglobulin (Ig) G (3). Initial Laboratory confi rmation lagged behind outbreak verifi cation human infection presumably occurs when humans are ex- by 3 months. Bundibugyo ebolavirus was less fatal (case- posed to infected body fl uids of the animal reservoir or fatality rate 34%) than Ebola viruses that had caused pre- intermediate host. Thereafter, person-to-person transmis- vious outbreaks in the region, and most transmission was sion occurs through direct contact with body fl uids of an associated with handling of dead persons without appropri- infected person (1,2,4). After an incubation period of 1–21 ate protection (adjusted odds ratio 3.83, 95% confi dence days (1,2,5), an acute febrile illness develops in infected interval 1.78–8.23).
  • Biography of Panelists for ADI- G-Cop

    Biography of Panelists for ADI- G-Cop

    BIOGRAPHY OF PANELISTS Dr. Matshidiso Rebecca Moeti WHO Regional Director for Africa World Health Organisation Brazzaville, Republic of Congo Matshidiso Moeti from Botswana the first woman WHO Regional Director for Africa has over the past 4 years, led the transformation of WHO Regional office for Africa into an accountable and results driven organisation. Over this period WHO AFRO has focused on improving health security, universal health coverage and supporting countries in the implementation of SDG-3. Strong partnerships have been developed with various bilateral and multilateral health development partners. Dr Moeti is a public health veteran, with more than 38 years of national and international experience. She joined WHO’s Africa Regional Office in 1999 and has served as Deputy Regional Director, Assistant Regional Director, Director of Noncommunicable Diseases, WHO Representative for Malawi, Coordinator of the Inter-Country Support Team for the South and East African countries and Regional Advisor for HIV/AIDs. She is renowned for having led WHO’s “3 by 5” Initiative in the African Region at the height of the HIV/AIDS epidemic, resulting in a significant increase in access to antiretroviral drugs by HIV-infected persons. Prior to joining WHO, she worked with UNAIDS as a Team Leader of the Africa and Middle East Desk in Geneva (1997-1999); with UNICEF as a Regional Health Advisor for East and Southern Africa; and with Botswana’s Ministry of Health as a Clinician and Public Health Specialist. Dr Moeti holds a degree in medicine (M.B., B.S) and Master’s degree in public health (MSc in Community Health for Developing Countries) from the Royal Free Hospital School of Medicine, University of London and the London School of Hygiene and Tropical Medicine, respectively.